LMAT241220C40000
- 0.00
- 0.000.00%
LeMaitre Vascular Newsroom
With EPS Growth And More, LeMaitre Vascular (NASDAQ:LMAT) Makes An Interesting Case
LeMaitre Vascular | 10-Q: Q3 2024 Earnings Report
LeMaitre Vascular Third Quarter 2024 Earnings: Beats Expectations
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $93 to $105
LeMaitre Vascular To Go Ex-Dividend On November 21st, 2024 With 0.16 USD Dividend Per Share
LeMaitre Vascular Declares $0.16 Dividend
LeMaitre to Participate at Upcoming Investor Conferences in November
LeMaitre Vascular Shares Are Trading Higher After Barrington Research and Oppenheimer Raised Their Respective Price Targets on the Stock.
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $93
LeMaitre Vascular Analyst Ratings
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $93 to $100
Express News | LeMaitre Vascular Inc : Stifel Raises Target Price to $100 From $95
LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript Summary
LeMaitre Vascular, Inc. (LMAT) Q3 2024 Earnings Call Transcript
LeMaitre Vascular Q3 Earnings, Sales Increase; Q4 Guidance Set
LeMaitre Vascular GAAP EPS of $0.49 Beats by $0.06, Revenue of $54.82M Beats by $1.31M
GUIDANCE: (LMAT) LEMAITRE VASCULAR Expects Fiscal Year 2024 EPS $1.91 - $1.96
Express News | LeMaitre Vascular Inc Outlook FY Sales $219.0Mm - $221.0Mm
Earnings Flash (LMAT) LEMAITRE VASCULAR Reports Q3 Revenue $54.8M